Exercise Dose and Metformin for Vascular Health in Metabolic Syndrome
Exercise Dose and Metformin for Vascular Health in Adults With Metabolic Syndrome
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Listed as NCT03355469, this PHASE2/PHASE3 trial focuses on Metabolic Syndrome and remains completed. Sponsored by National Heart, Lung, and Blood Institute (NHLBI), it has been updated 11 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Oct 2025 — Present [monthly]
Completed PHASE2/PHASE3
-
Apr 2025 — Oct 2025 [monthly]
Completed PHASE2/PHASE3
-
Sep 2024 — Apr 2025 [monthly]
Completed PHASE2/PHASE3
Status: Recruiting → Completed
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
May 2023 — Jul 2024 [monthly]
Recruiting PHASE2_PHASE3
Status: Active Not Recruiting → Recruiting
▶ Show 6 earlier versions
-
Jan 2023 — May 2023 [monthly]
Active Not Recruiting PHASE2_PHASE3
Phase: PHASE4 → PHASE2_PHASE3
-
Feb 2021 — Jan 2023 [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
-
Jan 2021 — Feb 2021 [monthly]
Recruiting PHASE4
-
Feb 2019 — Jan 2021 [monthly]
Recruiting PHASE4
-
Jun 2018 — Feb 2019 [monthly]
Recruiting PHASE4
-
Dec 2017 — Jun 2018 [monthly]
Recruiting PHASE4
First recorded
Aug 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Heart, Lung, and Blood Institute (NHLBI)
- Rutgers University
For direct contact, visit the study record on ClinicalTrials.gov .